Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

20%

Ph phase_2

20%

Ph phase_1

40%

Ph phase_4

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

2(40.0%)

Phase 2Efficacy & side effects

1(20.0%)

Phase 4Post-market surveillance

1(20.0%)

N/ANon-phased studies

1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Terminated(1)

Detailed Status

Completed3

Not yet recruiting1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 12 (40.0%)

Phase 21 (20.0%)

Phase 41 (20.0%)

N/A1 (20.0%)

Trials by Status

not_yet_recruiting120%

withdrawn120%

completed360%

Recent Activity

0 active trials

Showing 5 of 5

not_yet_recruitingphase_4

Lorazepam for Delirium Prevention in Critically Ill Patients With High Anttila-Index

NCT07428681

withdrawnphase_2

Clinical Trials (5)

Showing 5 of 5 trials

NCT07428681Phase 4

Lorazepam for Delirium Prevention in Critically Ill Patients With High Anttila-Index

Not Yet Recruiting

NCT06496854Phase 2

Prescribing Lorazepam for IUD Insertion: Pilot Feasibility Study

Withdrawn

NCT03300947Phase 1

Psilocybin for Treatment of Obsessive Compulsive Disorder

Completed

NCT03829839Phase 1

Effects of Oxytocin and Lorazepam on Fear-related Intra-amygdalar Activity

Completed

NCT02863614Not Applicable

Analgesia for Endometrial Scratching

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5